Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-30

Clinical Trial Update: A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium [Phase 3]

View source ↗

Summary

Phase 3 study evaluating whether adding lamotrigine to lithium improves depressive symptoms in bipolar disorder, including bipolar depression; the trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)
  • Lithium carbonate (Lithium carbonate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Bipolar Disorder, Bipolar Depression | Phase 3 | Status: COMPLETED